Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Will an Unlikely Dynamic Duo Take On Hepatitis C?

Posted by Paul Darling on Tue, Nov 17, 2015

As a number of healthcare partnerships, mostly in the form of accountable care organizations (ACOs), have recently formed, agreements between stakeholders outside of these ACOs are less common as many companies see the healthcare market as a zero-sum game. Contract negotiations between payers and providers over reimbursement levels or the exclusion of Gilead’s hepatitis C drugs by Express Scripts are more representative of the conflicts between stakeholders in the healthcare ecosystem.

Read More

Topics: accountable care organization (ACO), aco, ACA, Hepatitis C, Paul Darling, Hep C

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.